Rafael Simó Canonge-rekin lankidetzan egindako argitalpenak (8)

2023

  1. Disruption of cortical cell type composition and function underlies diabetes-associated cognitive decline

    Diabetologia, Vol. 66, Núm. 8, pp. 1557-1575

2022

  1. Accelerated amyloid angiopathy and related vascular alterations in a mixed murine model of Alzheimer´s disease and type two diabetes

    Fluids and Barriers of the CNS, Vol. 19, Núm. 1

  2. Common pathways in dementia and diabetic retinopathy: understanding the mechanisms of diabetes-related cognitive decline

    Trends in Endocrinology and Metabolism, Vol. 33, Núm. 1, pp. 50-71

2020

  1. Effect of topical administration of somatostatin on retinal inflammation and neurodegeneration in an experimental model of diabetes

    Journal of Clinical Medicine, Vol. 9, Núm. 8, pp. 1-18

2016

  1. Effects of the neuroprotective drugs somatostatin and brimonidine on retinal cell models of diabetic retinopathy

    Acta Diabetologica, Vol. 53, Núm. 6, pp. 957-964

  2. Modulation of microglia polarization dynamics during diabetic retinopathy in db/db mice

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1862, Núm. 9, pp. 1663-1674

  3. Somatostatin protects photoreceptor cells against high glucose–induced apoptosis

    Molecular Vision, Vol. 22, pp. 1522-1531

  4. Topical administration of GLP-1 receptor agonists prevents retinal neurodegeneration in experimental diabetes

    Diabetes, Vol. 65, Núm. 1, pp. 172-187